Guru Ownership Trend
Guru Analysis for Rapport Therapeutics, Inc. (RAPP)
Rapport Therapeutics, Inc. (RAPP), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 1 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $662,937.24.
Top institutional holders include Cliff Asness.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $264,176.53 net outflow during the quarter.
Recent activity highlights Cliff Asness who increased their stake by 3.7%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Rapport Therapeutics, Inc. (RAPP)
Major holders include Cliff Asness ($1.1 M). According to the latest reported data, 1 tracked investment managers collectively hold approximately 26,454 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $264,176.53, with 1 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 0 managers trimmed their positions, while 1 fully exited RAPP. The total reported sell value was $303,513.
Yes, 0 managers opened new positions in RAPP, and 1 increased their existing holdings. The total reported buy value was $39,336.47.